Investor Relations (IR) and Public Relations (PR) Consulting
Centerra Consulting is a San Diego-based boutique consulting firm founded in 2012 that provides investor relations, public relations, business development, and project management services to small to mid-size biotech, pharmaceutical, and medical device companies.
- Company typePrivate
- Founded2012
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Investor Relations (IR) and Public Relations (PR) Consulting does
Centerra Consulting, LLC is a private boutique management consulting firm founded in 2012 and headquartered in San Diego, California. The firm provides advisory and implementation services across three integrated practice areas: Investor Relations (IR) and Public Relations (PR), Business Development, and Project Management. Centerra targets small to mid-size biotech, pharmaceutical, and medical device companies, with a stated mission of bridging the gap between corporate vision and execution — operationalizing strategic plans while internal teams manage day-to-day operations.
The firm's service portfolio spans IR/PR work (IR presentations, earnings call scripts, road shows, investor day programs, equity/debt offerings, crisis communications), Business Development (deal presentations, due diligence management, alliance leadership, contract negotiation, partnership termination), and Project Management (PMO setup, portfolio management, project turnarounds, PMI-based processes). The firm emphasizes confidentiality and discretion for sensitive engagements. Underlying delivery is entirely human-led professional services with no proprietary technology platform, software product, API, or AI/ML components disclosed.
Centerra operates on a fee-for-service, quote-based pricing model with multi-year contracts and no publicly disclosed pricing tiers. The go-to-market motion is sales-led and relationship-driven, relying on direct outreach, phone inquiries, website contact, and professional network referrals from the founder's 20+ years of life sciences industry connections (Hybritech, Ligand, Amgen, Amylin Pharmaceuticals). The firm is founder-led by Christine Zedelmayer, serves as Managing Principal, and operates with 1-10 employees and no disclosed external funding.
Investor Relations (IR) and Public Relations (PR) Consulting firmographics
Firmographics- Name
- Investor Relations (IR) and Public Relations (PR) Consulting
- Legal name
- Centerra Consulting, LLC
- Website
- https://askcenterra.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Centerra Consulting is a San Diego-based boutique consulting firm founded in 2012 that provides investor relations, public relations, business development, and project management services to small to mid-size biotech, pharmaceutical, and medical device companies.
- Ownership category
- akta.pro rank
Investor Relations (IR) and Public Relations (PR) Consulting industry classification
Industry- Product category
- Life Sciences Management Consulting
- NAICS
- Management Consulting Services (54161), Marketing Consulting Services (541613)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG)
- akta.pro secondary industries
- Strategy & Corporate Development Consulting (BPAHACAA), Customer, Marketing & Sales Consulting (BPAHACAG)
Keywords
Where Investor Relations (IR) and Public Relations (PR) Consulting is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Investor Relations (IR) and Public Relations (PR) Consulting business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Revenue model
- Consulting Services: Centerra generates revenue through professional consulting engagements in investor relations, public relations, business development, and project management. The firm serves small to mid-size biotech, pharmaceutical, and medical device companies on a fee-for-service basis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom consulting engagements - quote-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Investor Relations (IR) and Public Relations (PR) Consulting product offering
Product offeringCore offering
Centerra Consulting provides three integrated consulting practices to small and mid-size biotech, pharmaceutical, and medical device companies: Investor Relations & Public Relations (IR presentations, earnings call scripts, consensus management, road shows, investor days, equity/debt offerings, annual reports, IR website development, crisis communications), Business Development (deal presentations, due diligence, transition and integration management, alliance leadership, governance, partnership termination, contract negotiation), and Project Management (PMO setup, portfolio management, project turnarounds, planning, monitoring, risk management, delivered using PMI-based processes).
Product overview
Centerra Consulting is a management consulting firm founded in 2012 and based in San Diego, CA, offering a portfolio of three integrated consulting services: Investor Relations & Public Relations, Business Development, and Project Management. The three service lines work together to help small-to-mid-size biotech, pharmaceutical, and medical device companies bridge the gap between vision and execution — from communicating corporate performance to investors and analysts, to structuring and negotiating partnerships and alliances, through to implementing and operationalizing strategic initiatives.
Differentiator
Problem solved
Functional benefit
Products and services
- Investor Relations & Public Relations Investor Relations and Public Relations consulting services for small to mid-size biotech, pharmaceutical, and medical device companies. Deliverables include IR presentations, earnings call scripts and PR, consensus management, road shows and bus tours, investor day programs, equity and debt offerings, annual reports, annual shareholder meetings, IR website development, and crisis communications.
- Business Development Business development consulting for life sciences clients, covering deal presentations, due diligence management, transition services, integration management, alliance leadership, governance practices and process, issue management and resolution, partnership termination activities, collaborative management, and contract negotiation.
- Project Management Project management consulting for life sciences companies, including project management leadership, project turnarounds, PMO setup, portfolio management, project selection and ROI analysis, project planning and assessment, project monitoring and reporting, risk and issue management, stakeholder engagement, and change control processes, delivered using PMI-based standard project management processes.
Quantifiable outcome
- Raised over $200M in equity for Amylin Pharmaceuticals
- +3 more outcomes
Companies that use Investor Relations (IR) and Public Relations (PR) Consulting
Customer profileSegments1 record
Ideal customer profiles1 record
Investor Relations (IR) and Public Relations (PR) Consulting technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Investor Relations (IR) and Public Relations (PR) Consulting partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights3 records
Investor Relations (IR) and Public Relations (PR) Consulting competitors and assessment
Company assessmentDirect peers
- Canale Communications: Life sciences-focused communications and investor relations firm serving public and private biotech, pharma, and medical device companies. Overlaps with Centerra's IR/PR service line and small/mid-cap segment focus.
- LaVoieHealthScience: Integrated investor relations, public relations, and strategic communications firm dedicated to health and life sciences. Highly comparable to Centerra in bundled IR/PR offering and small/mid-cap biotech and pharma target market.
- Russo Partners: Specialized investor relations and corporate communications firm focused on life sciences and healthcare. Comparable to Centerra in serving small/mid-cap biotechs and medical device companies with senior-led, relationship-driven engagements.
- Rx Communications (ICR Rx): Healthcare-focused investor relations and public relations firm serving specialty pharma and biotech. Comparable to Centerra in IR/PR advisory and small/mid-cap life sciences segment, now operating under the broader ICR umbrella.
- LifeSci Advisors: Boutique advisory firm focused exclusively on investor relations and communications for small and mid-cap life sciences companies. Closely comparable to Centerra in target customer, service mix (IR/PR advisory), and boutique delivery model.
- Westwicke Partners (ICR Westwicke): Healthcare-focused investor relations and strategic consulting firm serving public and pre-IPO life sciences companies. Directly comparable to Centerra's IR and shareholder communications practice, though with a larger team and broader geographic reach.
- Tiberend Strategic Advisors: Boutique investor relations and corporate communications firm focused on biotech and healthcare. Comparable to Centerra in senior-led, relationship-driven engagements for small and mid-cap life sciences clients.
- Burns McClellan: Healthcare and life sciences investor relations and corporate communications firm. Directly comparable to Centerra in serving emerging life sciences companies with IR strategy, communications, and capital markets advisory.
Emerging players
- ScientPR: Public relations and communications firm specializing in life sciences and biotech. Comparable to Centerra's PR service line for small and mid-cap life sciences clients, though with a narrower PR-only offering.
Broad incumbents
- ICR Inc. Large strategic communications and advisory firm with a dedicated healthcare and life sciences practice (including ICR Westwicke and ICR Rx). Overlaps with Centerra in IR/PR advisory but operates at much larger scale and with broader sector coverage.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Investor Relations (IR) and Public Relations (PR) Consulting social profiles
Digital presenceInvestor Relations (IR) and Public Relations (PR) Consulting financial estimates
Financial estimateRevenue estimate
Valuation estimate
Investor Relations (IR) and Public Relations (PR) Consulting leadership team
Management profileNumber of profiles
Profiles1 record
Investor Relations (IR) and Public Relations (PR) Consulting funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Investor Relations (IR) and Public Relations (PR) Consulting M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Investor Relations (IR) and Public Relations (PR) Consulting
What does Investor Relations (IR) and Public Relations (PR) Consulting do?
Centerra Consulting provides three integrated consulting practices to small and mid-size biotech, pharmaceutical, and medical device companies: Investor Relations & Public Relations (IR presentations, earnings call scripts, consensus management, road shows, investor days, equity/debt offerings, annual reports, IR website development, crisis communications), Business Development (deal presentations, due diligence, transition and integration management, alliance leadership, governance, partnership termination, contract negotiation), and Project Management (PMO setup, portfolio management, project turnarounds, planning, monitoring, risk management, delivered using PMI-based processes).
Is Investor Relations (IR) and Public Relations (PR) Consulting a public or private company?
Investor Relations (IR) and Public Relations (PR) Consulting is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Investor Relations (IR) and Public Relations (PR) Consulting founded?
Investor Relations (IR) and Public Relations (PR) Consulting was founded in 2012. It employs 1 to 10 people.
Where is Investor Relations (IR) and Public Relations (PR) Consulting based?
Investor Relations (IR) and Public Relations (PR) Consulting is headquartered in San Diego, United States, in the North America region.
How does Investor Relations (IR) and Public Relations (PR) Consulting make money?
One revenue line is on record: consulting Services.
Who are Investor Relations (IR) and Public Relations (PR) Consulting's main competitors?
Direct peers on record are Canale Communications, LaVoieHealthScience, Russo Partners, Rx Communications (ICR Rx), LifeSci Advisors, Westwicke Partners (ICR Westwicke), Tiberend Strategic Advisors and Burns McClellan. ScientPR is listed as an emerging player. ICR Inc. is listed as a broad incumbent.
Does Investor Relations (IR) and Public Relations (PR) Consulting have an API?
No public API is recorded for Investor Relations (IR) and Public Relations (PR) Consulting.
What industry is Investor Relations (IR) and Public Relations (PR) Consulting in?
Investor Relations (IR) and Public Relations (PR) Consulting's product category is Life Sciences Management Consulting. Its primary akta.pro industry code is BPAHAOAG, Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs), with a secondary code of BPAHACAA, Strategy & Corporate Development Consulting. Its NAICS code is 54161 and its SIC code is 8742.